Tommy G Thompson has bought stock on 8 days since Nov 2016
Director at United Therapeutics Corporation, and 4 other companies
SEC CIK 0001324863 · Filings on SEC.gov ↗
Tommy G Thompson's record
3 months after each buy, from the first price a copier could get.
3 buys since 2016 with 3 months of prices.
Companies
Every filing
28 filings since Feb 2016, newest first
United Therapeutics Corp
Director
United Therapeutics Corp
Director
United Therapeutics Corp
Director
Healthpeak Properties, Inc.
Director
Healthpeak Properties, Inc.
Director
United Therapeutics Corp
Director
Physicians Realty Trust
Director
Centene Corp
Director
Centene Corp
Director
United Therapeutics Corp
Director
United Therapeutics Corp
Director
Centene Corp
Director
Centene Corp
Director
United Therapeutics Corp
Director
Centene Corp
Director
Centene Corp
Director
United Therapeutics Corp
Director
Physicians Realty Trust
Director
Physicians Realty Trust
Director
Therapeuticsmd, Inc.
Director
Therapeuticsmd, Inc.
Director
United Therapeutics Corp
Director
Physicians Realty Trust
Director
United Therapeutics Corp
Director
United Therapeutics Corp
Director
Bard C R Inc /nj/
Director
United Therapeutics Corp
Director
Bard C R Inc /nj/
Director
About Tommy G Thompson
Tommy G. Thompson is a distinguished public servant and healthcare executive who has served as an independent Director on the Board of Directors of United Therapeutics Corporation (UTHR) since January 1, 2010.( Recently, as a corporate insider, he engaged in trading activities, including exercising 2,000 stock options, acquiring shares, and selling 2,000 common shares on March 4, 2026, at an average price of $489.42 for $978,840, as well as other disposals reported around March 6, 2026.(
Thompson's career highlights include serving four terms as Governor of Wisconsin (1987–2001), where he led economic revitalization, welfare reform, and healthcare access expansion, and as U.S. Secretary of Health and Human Services (2001–2005), advocating for national health and welfare policies.( He holds a B.S. and J.D. from the University of Wisconsin–Madison and has held post-public service roles such as partner at Akin Gump Strauss Hauer & Feld LLP (2005–2012), Independent Chairman of the Deloitte Center for Health Solutions (2005–2009), Interim President of the University of Wisconsin System (2020–2022), and current Chairman of the Board at TherapeuticsMD (TXMD) and other public companies like Healthpeak Properties.( He is also CEO of Thompson Holdings, focusing on healthcare solutions.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.